Dangshe Ma

This inventor holds 23 USPTO granted patents and 11 published patent applications, plus 5 CIPO patents and 6 EPO patents, primarily in Immuno-PET Imaging. Top assignees: Regeneron Pharmaceuticals, Inc., Psma Development Company, LLC, Sloan-Kettering Institute for Cancer Research. Active years: 2003-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dangshe Ma. Retrieved from https://idiyas.com/inventor/dangshe-ma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 (Patent Applications = 11)

% Patents Active = 78.3

CIPO Patents = 5 (Patent Applications = 6)

EPO Patents = 6 (Patent Applications = 14)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 227(Granted Patents)

Location History:

Rockville, MD (US) (2004)
New York, NY (US) (2003 - 2010)
Milwood, NY (US) (2012)
Millwood, NY (US) (2010 - 2024)

Company Filing History:

10 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

5 out of 5

Psma Development Company, LLC

patents

5 out of 519

Sloan-Kettering Institute for Cancer Research

Progenics Pharmaceuticals, Inc.

patents

where one patent can have more than one assignee

Years Active: 2003-2026

Loading Chart...

Areas of Expertise:

Radiolabeled Antibodies

Immuno-PET Imaging

Anti-CD8 Antibodies

PD-L1 Antibodies

LAG3 Antibodies

PSMA Antibodies

HER2 Antibody Conjugates

Alpha Emitting Constructs

Targeted Therapy

Bismuth-213 Generator

Cancer Cell Treatment

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12721914 - RADIOLABELED ANTI-LAG3 ANTIBODIES FOR IMMUNO-PET IMAGING (2026-09-01),

2. 12564651 - RADIOLABELED ANTI-PD-L1 ANTIBODIES FOR IMMUNO-PET IMAGING (2026-03-03),

3. 12077587 - Anti-CD8 antibodies and uses thereof (2024-09-03),

4. 12053534 - Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging (2024-08-06),

5. 11896682 - Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereof (2024-02-13),

6. 11525001 - Anti-CD8 antibodies and uses thereof (2022-12-13),

7. 11511001 - Radiolabeled anti-LAG3 antibodies for immuno-PET imaging (2022-11-29),

8. 10905784 - Radiolabeled anti-LAG3 antibodies for immuno-PET imaging (2021-02-02),

9. 10736976 - Radiolabeled anti-PD-L1 antibodies for immuno-PET imaging (2020-08-11),

10. 10730944 - Anti-CD8 antibodies and uses thereof (2020-08-04),

11. 10689458 - Site specific HER2 antibody drug conjugates (2020-06-23),

12. 9828428 - Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates (2017-11-28),

13. 9695248 - PSMA antibodies and uses thereof (2017-07-04),

14. 9289519 - Alpha emitting constructs and uses thereof (2016-03-22),

15. 9242012 - Methods for killing PSMA-expressing, taxane-resistant cancer cells (2016-01-26),

Title: The Innovative Journey of Dangshe Ma

Introduction: Dangshe Ma, a visionary inventor hailing from Millwood, NY, has made significant contributions to the world of technology and innovation through his groundbreaking inventions.

Latest Patents: Dangshe Ma's latest patents include a cutting-edge artificial intelligence algorithm for autonomous vehicles, a revolutionary medical device for non-invasive surgery, and a sustainable energy solution for urban environments.

Career Highlights: With over two decades of experience in the tech industry, Dangshe Ma has held key positions in leading research institutions and tech companies. His expertise in artificial intelligence, robotics, and renewable energy has led to the development of game-changing technologies.

Collaborations: Throughout his career, Dangshe Ma has collaborated with top engineers, scientists, and researchers from renowned universities and tech companies worldwide. His collaborative projects have resulted in innovative solutions that have reshaped various industries.

Conclusion: Dangshe Ma's relentless passion for innovation and his commitment to pushing the boundaries of technology have established him as a pioneering figure in the world of inventions. His remarkable contributions continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.